Índice

• • ·Curing COVID-19

    Página :1101

     
• • ·Pathologists in pursuit of the COVID-19 culprit

    Página :1102-1103

    Eunhee S Yi, Matthew J Cecchini, Melanie C Bois

     
• • ·Household studies provide key insights on the transmission of, and susceptibility to, SARS-CoV-2

    Página :1103-1104

    Virginia E Pitzer, Ted Cohen

     
• • ·Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices

    Página :1105-1106

    Chandini Raina MacIntyre

     
• • ·Colistin resistance in China: from outer membrane to One Health

    Página :1106-1108

    Federico Perez, Robert A Bonomo

     
• • ·Real-world antibiotic needs for resistant Gram-negative infections

    Página :1108-1109

    Margaret A Fitzpatrick

     
• • ·Surgical antibiotic prophylaxis: more is not better

    Página :1110-1111

    Sally A Roberts, Arthur J Morris

     
• • ·Chikungunya vaccine: a single shot for a long protection?

    Página :1111-1112

    Marie Mura, Jean Nicolas Tournier

     
• • ·A new dawn for the management of influenza?

    Página :1112-1114

    Glenn S Tillotson

     
• • ·Persistence of US measles risk due to vaccine hesitancy and outbreaks abroad

    Página :1114-1115

    Lauren Gardner, Ensheng Dong, Kamran Khan, Sahotra Sarkar

     
• • ·Long-term consequences of COVID-19: research needs

    Página :1115-1117

    Dana Yelin, Eytan Wirtheim, Pauline Vetter, Andre C Kalil, Judith Bruchfeld, Michael Runold, Giovanni Guaraldi, Cristina Mussini, Carlota Gudiol, Miquel Pujol, Alessandra Bandera, Luigia Scudeller, Mical Paul, Laurent Kaiser, Leonard Leibovici

     
• • ·Chloroquine or hydroxychloroquine for prophylaxis of COVID-19

    Página :1118

    Nicola Principi, Susanna Esposito

    
• • ·Hydroxychloroquine prophylaxis for COVID-19 contacts in India

    Página :1118-1119

    Sahaj Rathi, Pranav Ish, Ashwini Kalantri, Shriprakash Kalantri

    
• • ·Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach

    Página :1119-1120

    Praveen Tilangi, Devashish Desai, Adil Khan, Manish Soneja

    
• • ·Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?

    Página :1120-1121

    TP Afra, Muhammed Razmi T, Anuradha Bishnoi, NA Bishurul Hafi

    
• • ·Making decisions to mitigate COVID-19 with limited knowledge

    Página :1121-1122

    Weituo Zhang, Bi-yun Qian

    
• • ·Plea for multitargeted interventions for severe COVID-19

    Página :1122-1123

    Benjamin Jean Gaborit, Jean-François Bergmann, Cristina Mussini, Jose Ramon Arribas, Georg Behrens, Sharon Walmsley, Anton Pozniak, François Raffi

    
• • ·Protecting workers aged 60–69 years from COVID-19

    Página :1123

    Judith R Glynn

    
• • ·Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA

    Página :1123-1125

    Chad R Wells, Meagan C Fitzpatrick, Pratha Sah, Affan Shoukat, Abhishek Pandey, Abdulrahman M El-Sayed, Burton H Singer, Seyed M Moghadas, Alison P Galvani

      
• • ·Use of polymyxins in Chinese hospitals

    Página :1125-1126

    Rong Zhang, Yingbo Shen, Timothy R Walsh, Yang Wang, Fupin Hu

     
• • ·mcr-1 and plasmid prevalence in Escherichia coli from livestock

    Página :1126

    Yi-Yun Liu, Qiaoli Zhou, Wanyun He, Qingqing Lin, Jun Yang, Jian-Hua Liu

     
• • ·Correction to Lancet Infect Dis 2020; published online Aug 3. https://doi.org/10.1016/S1473-3099(20)30589-2

    Página :e250

    
• • ·Correction to Lancet Infect Dis 2020; 20: e192–97

    Página :e250

    
• • ·COVID-19 in Africa: half a year later

    Página :1127

    Munyaradzi Makoni

     
• • ·The arrival of Sputnik V

    Página :1128

    Vijay Shankar Balakrishnan

     
• • ·COVID-19 claims another victim

    Página :1129-1130

    Talha Burki

     
• • ·Infectious disease surveillance update

    Página :1130

    Ruth Zwizwai

    Esquema Esquema
• • ·Research brief

    Página :1131

    Sharmila Devi

    Esquema Esquema
• • ·Evelina Tacconelli—two viruses, two wars

    Página :1132

    Tony Kirby

     
• • ·The big disease with a little name

    Página :1133

    Talha Burki

     
• • ·Cholera: Zimbabwe’s unsung political victim

    Página :1134

    Munyaradzi Makoni

     
• • ·Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

    Página :1135-1140

    Luca Carsana, Aurelio Sonzogni, Ahmed Nasr, Roberta Simona Rossi, Alessandro Pellegrinelli, Pietro Zerbi, Roberto Rech, Riccardo Colombo, Spinello Antinori, Mario Corbellino, Massimo Galli, Emanuele Catena, Antonella Tosoni, Andrea Gianatti, Manuela Nebuloni

    Resumen Resumen Esquema Esquema  
• • ·Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study

    Página :1141-1150

    Qin-Long Jing, Ming-Jin Liu, Zhou-Bin Zhang, Li-Qun Fang, Jun Yuan, An-Ran Zhang, Natalie E Dean, Lei Luo, Meng-Meng Ma, Ira Longini, Eben Kenah, Ying Lu, Yu Ma, Neda Jalali, Zhi-Cong Yang, Yang Yang

    Resumen Resumen Esquema Esquema   
• • ·Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

    Página :1151-1160

    Adam J Kucharski, Petra Klepac, Andrew J K Conlan, Stephen M Kissler, Maria L Tang, Hannah Fry, Julia R Gog, W John Edmunds, CMMID COVID-19 working group, Jon C Emery, Graham Medley, James D Munday, Timothy W Russell, Quentin J Leclerc, Charlie Diamond, Simon R Procter, Amy Gimma, Fiona Yueqian Sun, Hamish P Gibbs, Alicia Rosello, Kevin van Zandvoort, Stéphane Hué, Sophie R Meakin, Arminder K Deol, Gwen Knight, Thibaut Jombart, Anna M Foss, Nikos I Bosse, Katherine E Atkins, Billy J Quilty, Rachel Lowe, Kiesha Prem, Stefan Flasche, Carl A B Pearson, Rein M G J Houben, Emily S Nightingale, Akira Endo, Damien C Tully, Yang Liu, Julian Villabona-Arenas, Kathleen O’Reilly, Sebastian Funk, Rosalind M Eggo, Mark Jit, Eleanor M Rees, Joel Hellewell, Samuel Clifford, Christopher I Jarvis, Sam Abbott, Megan Auzenbergs, Nicholas G Davies, David Simons

    Resumen Resumen Esquema Esquema   
• • ·Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study

    Página :1161-1171

    Yang Wang, Chunyan Xu, Rong Zhang, Yiqiang Chen, Yingbo Shen, Fupin Hu, Dejun Liu, Jiayue Lu, Yan Guo, Xi Xia, Junyao Jiang, Xueyang Wang, Yulin Fu, Lu Yang, Jiayi Wang, Juan Li, Chang Cai, Dandan Yin, Jie Che, Run Fan, Yongqiang Wang, Yan Qing, Yi Li, Kang Liao, Hui Chen, Mingxiang Zou, Liang Liang, Jin Tang, Zhangqi Shen, Shaolin Wang, Xiaorong Yang, Congming Wu, Shixin Xu, Timothy R Walsh, Jianzhong Shen

    Resumen Resumen Esquema Esquema   
• • ·Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study

    Página :1172-1181

    Jeffrey R Strich, Sarah Warner, Yi Ling Lai, Cumhur Y Demirkale, John H Powers, Robert L Danner, Sameer S Kadri

    Resumen Resumen Esquema Esquema   
• • ·Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis

    Página :1182-1192

    Stijn W de Jonge, Quirine J J Boldingh, Joseph S Solomkin, E Patchen Dellinger, Matthias Egger, Georgia Salanti, Benedetta Allegranzi, Marja A Boermeester

    Resumen Resumen Esquema Esquema   
• • ·Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

    Página :1193-1203

    Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar, Wolfgang Bender

    Resumen Resumen Esquema Esquema   
• • ·Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial

    Página :1204-1214

    Michael G Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, Melissa Mitchener, Kenji Tsuchiya, Takeki Uehara, Frederick G Hayden

    Resumen Resumen Esquema Esquema   
• • ·STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies

    Página :e251

    Tehmina Bharucha, Clarissa Oeser, Francois Balloux, Julianne R Brown, Ellen C Carbo, Andre Charlett, Charles Y Chiu, Eric C J Claas, Marcus C de Goffau, Jutte J C de Vries, Marc Eloit, Susan Hopkins, Jim F Huggett, Duncan MacCannell, Sofia Morfopoulou, Avindra Nath, Denise M O’Sullivan, Lauren B Reoma, Liam P Shaw, Igor Sidorov, Patricia J Simner, Le Van Tan, Emma C Thomson, Lucy van Dorp, Michael R Wilson, Judith Breuer, Nigel Field

    Resumen Resumen Esquema Esquema   
• • ·Monitoring approaches for health-care workers during the COVID-19 pandemic

    Página :e261

    Julia A Bielicki, Xavier Duval, Nina Gobat, Herman Goossens, Marion Koopmans, Evelina Tacconelli, Sylvie van der Werf

    Resumen Resumen Esquema Esquema  
• • ·Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential

    Página :e268

    Rosanna W Peeling, Debrah Boeras, Annelies Wilder-Smith, Amadou Sall, John Nkengasong

    Resumen Resumen Esquema Esquema  
• • ·Vaccinology: time to change the paradigm?

    Página :e274

    Christine Stabell Benn, Ane B Fisker, Andreas Rieckmann, Signe Sørup, Peter Aaby

    Resumen Resumen Esquema Esquema  
• • ·Purple urine bag syndrome: a colourful complication of urinary tract infection

    Página :1215

    Precil Diego Miranda de Menezes Neves, Bernadete Maria Coelho Ferreira, Sara Mohrbacher, Pedro Renato Chocair, Américo Lourenço Cuvello-Neto

     
• • ·Chlamydia pneumoniae mucositis syndrome

    Página :1216

    Vaibhav Mokashi, Mazen Bader